Dubin Daniel 4/A
4/A · PARDES BIOSCIENCES, INC. · Filed Dec 30, 2021
Insider Transaction Report
Form 4/AAmended
Dubin Daniel
Director
Transactions
- Conversion
Class A Common Stock
2021-12-23+30,000→ 30,000 total - Conversion
Class B Common Stock
2021-12-23−30,000→ 0 totalExercise: $0.00→ Class A Common Stock (30,000 underlying)
Footnotes (1)
- [F1]In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into shares of Class A Common Stock of the Issuer.